Fig. 3 | Scientific Reports

Fig. 3

From: Novel curcumin nanocarrier for targeting drug delivery of mitochondria proves efficacy in in vivo experiments on hepatocellular carcinoma mice models

Fig. 3

In vivo study of the nanocarriers in tumor-bearing mice. Dosing days (A). The formation of subcutaneous tumors after injection of Hepa1-6 cells in BALB/c mice (B). Tumor size variation in response to different treatments (C). Con = control, TD = targeted dendrimer without curcumin, FC = free curcumin, DC = non-targeted dendrimeric curcumin, TDC = mitochondria-targeted dendrimeric curcumin.

Back to article page